PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-347

  1. 1,061 Posts.
    lightbulb Created with Sketch. 532
    @PZ99 thanks for the excellent post.
    Please clarify if you know if the "exclusive" deal with Bene is exclusive of Bene supplying others, i thought it was that Bene committed to meet PAR's supply needs.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.